Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Nadolol MeSH Descriptor Data 2025


MeSH Heading
Nadolol
Tree Number(s)
D02.033.100.624.698.601
D02.033.755.624.698.601
D02.092.063.624.698.601
Unique ID
D009248
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D009248
Scope Note
A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor.
Entry Term(s)
Corgard
SQ-11725
Solgol
Pharm Action
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Sympatholytics
Registry Numbers
42200-33-9
0
CAS Type 1 Name
2,3-Naphthalenediol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-
Previous Indexing
Adrenergic Beta Receptor Blockaders (1969-1986)
Propanolamines (1974-1986)
Public MeSH Note
87
History Note
87
Date Established
1987/01/01
Date of Entry
1986/06/25
Revision Date
2013/07/08
Nadolol Preferred
Corgard Narrower
SQ-11725 Narrower
Solgol Narrower
page delivered in 0.134s